These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 15613935)
1. Induction of the rabbit syndrome following coadministration of paroxetine, perphenazine, and amitriptyline. Gourzis P; Polychronopoulos P; Argyriou AA; Bakalidou C; Beratis S Clin Neuropharmacol; 2004; 27(6):299-300. PubMed ID: 15613935 [TBL] [Abstract][Full Text] [Related]
2. [Likely serotoninergic syndrome from an interaction between amitryptiline, paroxetine, and linezolid]. Morales-Molina JA; Mateu-de Antonio J; Grau Cerrato S; Marín Casino M Farm Hosp; 2005; 29(4):292-3. PubMed ID: 16268747 [No Abstract] [Full Text] [Related]
3. Paroxetine potentiates the central nervous system side effects of perphenazine: contribution of cytochrome P4502D6 inhibition in vivo. Ozdemir V; Naranjo CA; Herrmann N; Reed K; Sellers EM; Kalow W Clin Pharmacol Ther; 1997 Sep; 62(3):334-47. PubMed ID: 9333110 [TBL] [Abstract][Full Text] [Related]
4. Platelet counts in depressed patients treated with amitriptyline or paroxetine. Lederbogen F; Hörer E; Hellweg R; Heuser I; Deuschle M Eur Psychiatry; 2003 Mar; 18(2):89-91. PubMed ID: 12711406 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome. Shad MU; Preskorn SH J Clin Psychopharmacol; 1998 Aug; 18(4):346-7. PubMed ID: 9690705 [No Abstract] [Full Text] [Related]
6. Comparison of tolerance of venlafaxine, paroxetine and amitriptyline in depression therapy. Miskovic M Med Arch; 2015 Apr; 69(2):107-9. PubMed ID: 26005260 [TBL] [Abstract][Full Text] [Related]
7. Severe weight gain induced by combination treatment with risperidone and paroxetine. Fukui H; Murai T Clin Neuropharmacol; 2002; 25(5):269-71. PubMed ID: 12410060 [TBL] [Abstract][Full Text] [Related]
8. Serotonin syndrome following the administration of tramadol with paroxetine. Lantz MS; Buchalter EN; Giambanco V Int J Geriatr Psychiatry; 1998 May; 13(5):343-5. PubMed ID: 9658268 [No Abstract] [Full Text] [Related]
9. Hyponatremia upon resumption of paroxetine therapy. Wakita M; Matsuoka H; Hamada R; Okatsu H; Nakajima T; Osame M Intern Med; 2005 Mar; 44(3):240-2. PubMed ID: 15805714 [TBL] [Abstract][Full Text] [Related]
10. [Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences]. Mosolov SN; Kostiukova EG; Gorodnichev AV; Timofeev IV Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):22-9. PubMed ID: 16281375 [TBL] [Abstract][Full Text] [Related]
11. Antidepressants and the risk of suicidal behaviors. Barbui C JAMA; 2004 Dec; 292(23):2833; author reply 2833. PubMed ID: 15598910 [No Abstract] [Full Text] [Related]
12. Rare case of serotonin syndrome with therapeutic doses of paroxetine. Paruchuri P; Godkar D; Anandacoomarswamy D; Sheth K; Niranjan S Am J Ther; 2006; 13(6):550-2. PubMed ID: 17122538 [TBL] [Abstract][Full Text] [Related]
13. [Serotonin syndrome associated to the use of paroxetine. Case report]. Cavallazzi LO; Grezesiuk AK Arq Neuropsiquiatr; 1999 Sep; 57(3B):886-9. PubMed ID: 10751931 [TBL] [Abstract][Full Text] [Related]
14. [A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine]. Hamada Y; Miyamoto K; Inatsugi Y; Suzuki H; Kusunoki S Rinsho Shinkeigaku; 2006 Aug; 46(8):575-8. PubMed ID: 17154040 [TBL] [Abstract][Full Text] [Related]